Research Shows GLP-1 Weight-Loss Drugs May Weaken Bones — What Older Adults Should Ask Their Doctor
Around 9% of adults in the United States (65 and older) have reportedly used GLP-1s like Ozempic and Wegovy. As ...
Sunday, June 21, 2026
Tag: GLP1
GLP-1 Coverage Update: How Medicare’s New Transitional Policies Could Lower Out-of-Pocket Costs for Weight-Loss Medications
For years, many seniors and retirees have faced a frustrating reality: popular GLP-1 medications like Wegovy and Zepbound could cost ...
Amazon Launches Nationwide GLP-1 Weight-Loss Program
Amazon is rolling out a new GLP-1 program aimed at simplifying access to popular weight-loss drugs, from doctor visits to ...
Foundayo, Wegovy and How GLP-1 Weight-Loss Pills Compare to Shots
As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles now have two options in pill form ...
GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics
As several Indian pharma giants race to launch cheaper generics for Semaglutide, the active ingredient in popular weight-loss drugs Ozempic ...
Marketing to Women in the GLP-1 Era: How Marketers Can Respond Responsibly
GLP-1 medications are more than just another fleeting trend in weight management. These science-backed interventions lower blood sugar, reduce the ...
-1024x683.jpg "Strait Outta Hormuz: Getting the Iran Oil Story Straight")
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.